South Africa Pharmaceuticals & Healthcare Report Q1 2018
BMI View: South Africa's pharmaceutical market will remain the largest and most developed in Sub- Saharan Africa. As such it will continue to attract multinational drugmakers looking to develop a foothold in the wider region. Given the size of the market, it is vital that companies appreciate the varying levels of both investment risk and reward that are present at the regional and provincial level in South Africa. Discrepancies at the state-level highlight the depth of healthcare inequality between South Africa's urban and rural populations.